Multiple Sclerosis News

Featured Research

Mar. 2, 2015 — A researcher has discovered a way to keep remyelination going, using a drug that's already on the market. Damage to myelin, the fatty insulator that enables communication between nerve cells, ... full story

Feb. 27, 2015 — A newly characterized group of pharmacological compounds block both the inflammation and nerve cell damage seen in mouse models of multiple sclerosis, according to a study. Multiple sclerosis is a ... full story

Feb. 27, 2015 — A new study explores what multiple sclerosis patients know, or want to know, about their physician’s financial relationship with the pharmaceutical company sponsoring clinical ... full story

Feb. 17, 2015 — A promising new approach to treat multiple sclerosis has been discovered by scientists. Multiple sclerosis (MS) is a progressive, often disabling neurological disease, which is most often diagnosed ... full story

Feb. 16, 2015 — Scientists have uncovered a marvel molecule that blocks a key driver of inflammatory diseases. The finding could meet a major unmet clinical need by inspiring new non-invasive treatments for ... full story

Feb. 9, 2015 — Scientist have documented the pathological progress of the disease from its early to late stage and also shown that inflammatory and neurodegenerative processes have a role to play. This raises the ... full story

Jan. 22, 2015 — Axons connect neurons with each other to form the neural networks that underpin the vital functions of perception, motility, cognition, and memory. In many neurodegenerative disorders, from traumatic ... full story

Jan. 21, 2015 — Insight into factors contributing to cognitive fatigue in multiple sclerosis have been gained through a new study. Cognitive fatigue, which is common in MS, has subjective and objective ... full story

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science&apos;s drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead&apos;s Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi&apos;s %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet&apos;s Keris Lahiff reports from New York.
Video provided by TheStreet

All Multiple Sclerosis News

Mar. 2, 2015 — A researcher has discovered a way to keep remyelination going, using a drug that's already on the market. Damage to myelin, the fatty insulator that enables communication between nerve cells, ... full story

Feb. 27, 2015 — A newly characterized group of pharmacological compounds block both the inflammation and nerve cell damage seen in mouse models of multiple sclerosis, according to a study. Multiple sclerosis is a ... full story

Feb. 27, 2015 — A new study explores what multiple sclerosis patients know, or want to know, about their physician’s financial relationship with the pharmaceutical company sponsoring clinical ... full story

Feb. 18, 2015 — A new treatment may bring hope for people who suffer from muscle cramps or spasms from neuromuscular disorders, diseases such as multiple sclerosis or simply from nighttime leg cramps that keep ... full story

Feb. 17, 2015 — A promising new approach to treat multiple sclerosis has been discovered by scientists. Multiple sclerosis (MS) is a progressive, often disabling neurological disease, which is most often diagnosed ... full story

Feb. 16, 2015 — Scientists have uncovered a marvel molecule that blocks a key driver of inflammatory diseases. The finding could meet a major unmet clinical need by inspiring new non-invasive treatments for ... full story

Feb. 9, 2015 — Scientist have documented the pathological progress of the disease from its early to late stage and also shown that inflammatory and neurodegenerative processes have a role to play. This raises the ... full story

Jan. 22, 2015 — Axons connect neurons with each other to form the neural networks that underpin the vital functions of perception, motility, cognition, and memory. In many neurodegenerative disorders, from traumatic ... full story

Jan. 21, 2015 — Insight into factors contributing to cognitive fatigue in multiple sclerosis have been gained through a new study. Cognitive fatigue, which is common in MS, has subjective and objective ... full story

Jan. 20, 2015 — A common gut microbe might curb the risk of developing multiple sclerosis -- at least in women -- suggests the largest study of its kind. If confirmed in other studies, this might prove the hygiene ... full story

Jan. 6, 2015 — Although some reports have suggested a link between human papillomavirus (HPV) vaccination and development of multiple sclerosis or other demyelinating diseases -- a group of central nervous system ... full story

Dec. 29, 2014 — Three years after a small number of patients with multiple sclerosis (MS) were treated with high-dose immunosuppressive therapy and then transplanted with their own hematopoietic stem cells, most of ... full story

Dec. 10, 2014 — An interdisciplinary team of neuroscientists and neurosurgeons has used a new imaging technique to show how the human brain heals itself in just a few weeks following surgical removal of a brain ... full story

Dec. 10, 2014 — Fatigue and pain, along with other symptoms, prevent many people with multiple sclerosis from exercising. But a new how-to guide for a home-based exercise program offers a way for people with MS to ... full story

Dec. 3, 2014 — A neurotoxin called acrolein found in tobacco smoke that is thought to increase pain in people with spinal cord injury has now been shown to accumulate in mice exposed to the equivalent of 12 ... full story

Dec. 2, 2014 — A rogue protein has been identified in multiple sclerosis, which attacks the body's central nervous system. Reporting for the first time, researchers believe this finding could pave the way for ... full story

Dec. 1, 2014 — A new article provides insight into the variable impact of traumatic brain injury on long-term memory. Memory impairment affects 54% to 84% of individuals with TBI. While the variable impact of TBI ... full story

Nov. 11, 2014 — Researchers have identified a key protein that is able to reduce the severity of a disease equivalent to multiple sclerosis in mice. This molecule, Del-1, is the same regulatory protein that has been ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.